The WVU School of Medicine has received a substantial grant to research developing treatment for antibiotic-resistant infections.
The grant was received through the U.S. Department of Defense's Defense Threat Reduction Agency, and totals $1.4 million. A research group will be led by assistant professor Mariette Barbier.
Antibiotics, which are vital to the recovery in medical advancements such as joint replacement, organ transplant, cancer therapy and treatment of chronic illnesses, are designed to prevent infections following these procedures, according to the Centers for Disease Control and Prevention.
However, because antibiotics have evolving versatility, it can result in rejection and ultimately defeat the drugs that were designed to kill them.